Screening for NEI Clinical Studies
NCT00001734 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2017-07-02
Summary
This screening protocol is designed to facilitate patient recruitment to National Eye Institute (NEI) clinical research studies. Patients must meet specific requirements of a research study; this protocol serves as a first step for admitting patients to an appropriate program.
Candidates may have a diagnosed or undiagnosed eye condition. They will be screened with a medical history, physical examination, eye examination and blood test. Other screening procedures may include routine laboratory tests, non-invasive imaging, and questionnaires. The eye examination includes measurement of eye pressure and dilation of the pupils to fully examine the lens, vitreous and retina. Specialized eye tests will be done only if needed to determine eligibility for a specific study. When the screening is completed, patients will be informed of their options to participate in a study. Patients who are found ineligible for a current study will be informed of alternative treatments or options. No treatment is offered under this protocol.
Conditions
- Conjunctivitis
- Iritis
- Keratitis
- Retinitis
- Uveitis
Sponsors & Collaborators
-
National Eye Institute (NEI)
lead NIH
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-03-23
- Completion
- 2008-10-03
Countries
- United States
Study Locations
More Related Trials
-
Immune Indicators of Uveitis
NCT00089739 ·Status: COMPLETED
-
Analysis of Eye Tissue
NCT00001224 ·Status: COMPLETED
-
Microbiome as a ThErapeutic Response Biomarker
NCT04721743 ·Status: WITHDRAWN
-
Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab
NCT00605943 ·Status: COMPLETED
-
Leflunomide to Treat Uveitis
NCT00001863 ·Status: COMPLETED ·Phase: PHASE2
-
Metagenomics for Ocular Inflammation
NCT06974162 ·Status: RECRUITING
-
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy
NCT00468871 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Uveitis/Intraocular Inflammatory Disease Biobank (iBank)
NCT02656381 ·Status: COMPLETED
-
UNICORNS: Uveitis in Childhood Prospective National Cohort Study
NCT05385757 ·Status: ACTIVE_NOT_RECRUITING
-
Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti
NCT00876434 ·Status: COMPLETED ·Phase: PHASE1
-
Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis
NCT00070759 ·Status: COMPLETED ·Phase: PHASE2
-
Uveitis Gene-Expression Profiling
NCT00874471 ·Status: COMPLETED
-
Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye
NCT00063765 ·Status: COMPLETED ·Phase: PHASE1
-
Sirolimus Injections for Autoimmune Scleritis
NCT01517074 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prospective Study to Validate the Imaging Biomarker for NCP (R33)
NCT05653921 ·Status: SUSPENDED
-
Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate
NCT01314417 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The Cohort Study of Uveitis Patients
NCT05727540 ·Status: RECRUITING
-
Screening for Oculocerebral Lymphoma with the Phenotype of NK Cells in Patients with Uveitis
NCT05388838 ·Status: RECRUITING ·Phase: NA
-
Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,
NCT01526889 ·Status: COMPLETED ·Phase: PHASE2
-
The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma
NCT00943982 ·Status: COMPLETED ·Phase: PHASE1
-
Topical Interferon Gamma for Macular Edema Secondary to Uveitis
NCT01376362 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis
NCT05523765 ·Status: COMPLETED ·Phase: PHASE2
-
Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis
NCT00043667 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis
NCT03207815 ·Status: TERMINATED ·Phase: PHASE2
-
Infliximab to Treat Non-Infectious Scleritis
NCT00075075 ·Status: COMPLETED ·Phase: PHASE1